Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients-Reference-Cited by-同舟云学术

Strategies to Prevent EBV Reactivation and Posttransplant Lymphoproliferative Disorders (PTLD) after Allogeneic Stem Cell Transplantation in High-Risk Patients

Published:2011-05 Issue:5 Volume:17 Page:591-597
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Reddy Nishitha,Rezvani Katayoun,Barrett A. John,Savani Bipin N.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference80 articles.

1. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases;Styczynski;Transpl Infect Dis,2009

2. Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors because of a change of T cell depletion technique;Meijer;Bone Marrow Transplant,2002

3. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation;Landgren;Blood,2009

4. Depletion of EBV-infected cells in donor marrow by counterflow elutriation;Gross;Exp Hematol,1998

5. The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation;Lucas;Blood,1996

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Herpes Viruses;International Encyclopedia of Public Health;2025

2. EBV Reactivation and Disease in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients and Its Impact on HSCT Outcomes;Viruses;2024-08-14

3. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2);Zeitschrift für Gastroenterologie;2024-05

4. Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes;International Journal of Molecular Sciences;2023-11-07

5. Hematopoietic stem cell transplantation and the noncytomegalovirus herpesviruses;Transplant Infectious Disease;2023-11